1. National Center for Biotechnology Information. PubChem Database. Hydrochlorothiazide. 2022. https://pubchem.ncbi.nlm.nih.gov/compound/Hydrochlorothiazide
2. Herman LL, Bashir K. Hydrochlorothiazide. Treasure Island (FL): StatPearls Publishing; 2022 Jan. https://www.ncbi.nlm.nih.gov/books/NBK430766/
3. Roush GC, Sica DA. Diuretics for Hypertension: A Review and Update. American Journal of Hypertension, 2016. 29(10), 1130–1137. doi:10.1093/ajh/hpw030
4. FDA. Hydrochlorothiazide Tablets, USP 12.5 mg, 25 mg and 50 mg. 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/040735s004,040770s003lbl.pdf.
5. Medscape. Hydrochlorothiazide (Rx). Drugs & Diseases. 2022. https://reference.medscape.com/drug/microzide-hydrodiuril-hydrochlorothiazide-342412#0.
8. Dhayat, N.A., et al., Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. BMC Nephrol, 2018. 19(1): p. 349. https://www.ncbi.nlm.nih.gov/pubmed/30526528
9. FDA. Microzide Capsules. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020504s018lbl.pdf.
10. Musini, V.M., et al., Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev, 2014(5): p. Cd003824.
11. Peng, X., et al., Hydrochlorothiazide Test as a Tool in the Diagnosis of Gitelman Syndrome in Chinese Patients. Front Endocrinol (Lausanne), 2018. 9: p. 559. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165878/
12. Roush, G.C., et al., Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis. J Clin Hypertens (Greenwich), 2018. 20(10): p. 1507-1515. https://www.ncbi.nlm.nih.gov/pubmed/30251403